Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000422 · ClinicalTrials.gov registry record · Phase 2
Tailored Treatments of Fibromyalgia
A Phase 2 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 2
- Development phase
- 312
- Enrollment target
NCT00000422 is a Phase 2 study that has completed, run by University of Washington. The registered enrollment target is 312 participants.
The verdict
NCT00000422, a Phase 2 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 312 participants
- Enrollment target
Study Summary
This study will evaluate the effects of matching treatments to people with fibromyalgia syndrome (FMS) on the basis of their psychosocial and behavioral characteristics. We will look at how patients respond to a rehabilitation program that includes physical therapy and information about fibromyalgia. We will combine this program with psychological treatments that are either matched or mismatched to the way patients cope with and adapt to symptoms of FMS. The second aim of our study is to better understand how different FMS symptoms may vary together and how these symptoms change as a result of treatment in a person's natural environment. People with FMS and healthy people of the same ages will record their moods, thoughts, symptoms, activities, and fatigue levels three times a day for 2 weeks. Participants will use palm-top computers to record these "real-time" assessments. This approach will permit people to rate how they feel at a particular time rather than looking back in time.
Interventions
- BEHAVIORAL Cognitive-behavioral psychotherapy and physical exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 312 participants |
| Start Date | 1998-07 |
| Est. Completion | 2004-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000422
The ClinicalTrials.gov registry entry for NCT00000422 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 312 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cognitive-behavioral psychotherapy and physical exercise is the first listed.
NCT00000422 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000422 about?
NCT00000422 is a clinical study titled "Tailored Treatments of Fibromyalgia". This study will evaluate the effects of matching treatments to people with fibromyalgia syndrome (FMS) on the basis of their psychosocial and behavioral characteristics. We will look at how patients respond to a rehabilitation program that includes physical therapy and information about fibromyalgia...
What is the current status of trial NCT00000422?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 312 participants. The study started on 1998-07. Estimated completion is 2004-05.
What interventions are being tested in trial NCT00000422?
The interventions under investigation include: Cognitive-behavioral psychotherapy and physical exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT00000422?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.